ProfileOfResearchers

211

TÃTULO: Correlation between the personality trait-anxiety and the wilingness to volunteer for participation in phase I studies.
AUTORES: Luis Almeida; Benedita Azevedo; Manuel Vaz da Silva; Teresa Nunes; Amilcar Falcao; Rui Coelho; Antonio Albino Teixeira ; Patricio Soares da Silva ;
PUBLICAÇÃO: 2006, FONTE: 25th Annual Meeting of the American-College-of-Clinical-Pharmacology in JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 46, NÚMERO: 9

INDEXADO EM:

WOS

212

TÃTULO: Steady-state pharmacokinetics of once-daily and twice-daily regimens of eslicarbazepine acetate (BIA 2-093) in healthy subjects
AUTORES: Luis Almeida; Amilcar Falcao; Joana Maia; Manuel Vaz da Silva; Patricio Soares da Silva ;
PUBLICAÇÃO: 2006, FONTE: 60th Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 47

INDEXADO EM:

WOS

213

TÃTULO: Effect of single-doses of nebicapone (BIA 3-202) on the catechol-O-methyltransferase (COMT) activity in healthy subjects
AUTORES: Almeida, L; Falcao, A; Vaz da Silva, M; Wright, L; Torrao, L; Igreja, B; Soares, E; Maia, J; Nunes, T; Soares da Silva, P ;
PUBLICAÇÃO: 2006, FONTE: 10th International Congress of Parkinson's Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 21

INDEXADO EM:

WOS

214

TÃTULO: The effects of ligand chain length, salt concentration and temperature on the adsorption of bovine serum albumin onto polypropyleneglycol-Sepharose Full Text
AUTORES: Dias Cabral, AC ; Ferreira, AS; Phillips, J; Queiroz, JA ; Pinto, NG;
PUBLICAÇÃO: 2005, FONTE: BIOMEDICAL CHROMATOGRAPHY, VOLUME: 19, NÚMERO: 8

INDEXADO EM:

Scopus

WOS

215

TÃTULO: Eslicarbazepine acetate (BIA 2-093): Relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200 mg and 800 mg tablet formulations
AUTORES: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLICAÇÃO: 2005, FONTE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46

INDEXADO EM:

WOS

216

TÃTULO: Relative bioavailability and bioequivalence of three different oral formulations of eslicarbazepine acetate
AUTORES: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLICAÇÃO: 2005, FONTE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46

INDEXADO EM:

WOS

217

TÃTULO: Effect of age and gender on the pharmacokinetics of eslicarbazepine acetate
AUTORES: Soares Da Silva, P ; Almeida, L; Falcao, A; Maia, J;
PUBLICAÇÃO: 2005, FONTE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46

INDEXADO EM:

WOS

218

TÃTULO: Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel inhibitor
AUTORES: Almeida, L; Falcao, A; Maia, J; Mazur, D; Gellert, M; da Silva, PS;
PUBLICAÇÃO: 2005, FONTE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46

INDEXADO EM:

WOS

219